We are live on ! Find out more
ZYNE

Zynerba Pharmaceuticals, Inc
ZYNE

Delisted

ZYNE was delisted on the 10th of October, 2023.

Back to rankings

76 hedge funds and large institutions have $115M invested in Zynerba Pharmaceuticals, Inc in 2019 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 22 increasing their positions, 7 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

823% more capital invested

Capital invested by funds: $12.5M → $115M (+$103M)

214% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 7

106% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 17

25% more funds holding

Funds holding: 61 → 76 (+15)

15% more call options, than puts

Call options by funds: $12.1M | Put options by funds: $10.5M

Holders
76
Holders Change
+15
Holders Change %
+24.59%
% of All Funds
1.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
22
Reduced
7
Closed
17
Calls
$12.1M
Puts
$10.5M
Net Calls
+$1.6M
Net Calls Change
+$2.53M

Top Buyers

Rank Fund Capital Flow
1
EMG
ETF Managers Group
New Jersey
+$25.8M
2
BlackRock
BlackRock
New York
+$11.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.98M
4
PCM
Portolan Capital Management
Massachusetts
+$7.24M
5
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$4.67M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.01M
2
CCM
Campbell Capital Management
Florida
-$958K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$824K
4
PP
PDT Partners
New York
-$476K
5
HighTower Advisors
HighTower Advisors
Illinois
-$364K
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
26
LPL Financial
California
$515K +$439K +38,020 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$434K +$370K +32,011 New
BWP
28
Bernardo Wealth Planning
Pennsylvania
$358K +$11.5K +1,000 +4%
New York State Common Retirement Fund
29
New York State Common Retirement Fund
New York
$289K +$246K +21,300 New
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$271K +$231K +20,000 New
Jane Street
31
Jane Street
New York
$244K +$208K +18,005 New
Millennium Management
32
Millennium Management
New York
$242K -$32.9K -2,853 -14%
CAN
33
Claraphi Advisory Network
United States
$237K +$63.9K +5,532 +46%
Deutsche Bank
34
Deutsche Bank
Germany
$223K +$191K +16,579 New
SG Americas Securities
35
SG Americas Securities
New York
$210K +$179K +15,473 New
Manulife (Manufacturers Life Insurance)
36
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$186K +$159K +13,761 New
Commonwealth Equity Services
37
Commonwealth Equity Services
Massachusetts
$182K +$156K +13,492 New
RJFSA
38
Raymond James Financial Services Advisors
Florida
$181K +$154K +13,322 New
AIG
39
American International Group
New York
$179K +$153K +13,220 New
RJA
40
Raymond James & Associates
Florida
$167K +$25.1K +2,175 +21%
Bank of America
41
Bank of America
North Carolina
$158K +$129K +11,139 +2,228%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$152K -$1.01M -87,465 -89%
Cetera Investment Advisers
43
Cetera Investment Advisers
Illinois
$151K +$125K +10,800 New
MIM
44
MetLife Investment Management
New Jersey
$150K +$128K +11,100 New
LTFS
45
Ladenburg Thalmann Financial Services
Florida
$143K -$11K -950 -8%
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$94K +$80.3K +6,956 New
CG
47
Cutler Group
California
$90K +$24.2K +2,100 +46%
SIAP
48
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$81K +$69.3K +6,000 New
TRCT
49
Tower Research Capital (TRC)
New York
$72K +$61K +5,287 New
Wells Fargo
50
Wells Fargo
California
$57K +$25.4K +2,204 +110%
1
2
3 4

ZYNE Hedge Fund Activity: Q2 2019 in Review

76 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Zynerba Pharmaceuticals, Inc (ZYNE) for Q2 2019, worth a combined $115M — up 823% from $12.5M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new ZYNE positions and 17 closed out — a net gain of 18 holders — while 22 added to existing stakes and 7 trimmed.

The largest buyer was ETF Managers Group, opening a new position worth an estimated $25.8M. The largest seller was Susquehanna International Group, cutting an estimated $1.01M.

  • 76 institutional investors held Zynerba Pharmaceuticals, Inc (ZYNE) as of Q2 2019, up from 61 in Q1 2019.
  • Funds reported $115M of Zynerba Pharmaceuticals, Inc stock for Q2 2019, up 823% quarter-over-quarter.
  • 35 funds opened new Zynerba Pharmaceuticals, Inc positions in Q2 2019 and 17 closed out, a net change of +18 holders.
  • The largest Zynerba Pharmaceuticals, Inc buyer in Q2 2019 was ETF Managers Group, an estimated $25.8M added.
  • The largest Zynerba Pharmaceuticals, Inc seller in Q2 2019 was Susquehanna International Group, an estimated $1.01M sold.

Based on aggregated 13F filings for Q2 2019.